Inventor · disambiguated record
Takahiro Ishiguro
Also filed as: ISHIGURO TAKAHIRO
11 granted patents·14 pending applications·207 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0196US7919086B2Anti-glypican 3 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Apr 5, 2011·74 cites·56 claims
- 0295US9975966B2Cytotoxicity-inducing theraputic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 22, 2018·25 cites·10 claims
- 0394US8497355B2Anti-glypican-3 antibody having improved kinetics in plasmaIGAWA TOMOYUKI·Filed 2008·Granted Jul 30, 2013·29 cites·16 claims
- 0493US11001643B2Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted May 11, 2021·9 cites·34 claims
- 0592US7867734B2Anti-glypican 3 antibody having modified sugar chainCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Jan 11, 2011·23 cites·8 claims
- 0691US11066483B2Cytotoxicity-inducing therapeutic agentNEZU JUNICHI·Filed 2011·Granted Jul 20, 2021·36 cites·48 claims
- 0785US2025250362A1Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0883US12479929B2Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Nov 25, 2025·0 cites·21 claims
- 0983US11505605B2T cell-redirected antigen-binding molecule for cells having immunosuppression functionCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Nov 22, 2022·3 cites·1 claims
- 1083US11072666B2Cell injury inducing therapeutic drug for use in cancer therapyCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 27, 2021·6 cites·17 claims
- 1174US11793180B2Gene-modified mouse expressing human GPC3 polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 24, 2023·2 cites·4 claims
- 1274US2025066503A1Cell injury inducing therapeutic drug for use in cancer therapyCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1372US2021230311A1Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1471US2022041756A1Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1568US2024239890A1Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1661US2021388110A1Cell injury inducing therapeutic drug for use in cancer therapyCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1756US2013295612A1Anti-glypican-3 antibody having improved kinetics in plasmaCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1851US11612149B2Non-human animal having human CD3 gene substituted for endogenous CD3 geneCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 28, 2023·0 cites·8 claims
- 1950US2022348658A1Anti-t cell antigen-binding molecule to be used in combination with cytokine inhibitorCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2050US2011104157A1Liver cancer drugCHUGAI PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 2148US2020123256A1Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 2247US2010248359A1Anti-Glypican 3 AntibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 2346US2015259417A1Anti-Glypican 3 AntibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 2446US2015315278A1Anti-Glypican-3 Antibody Having Improved Kinetics in PlasmaCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 2546US2011033452A1Anti-Glypican 3 Antibody Having Modified Sugar ChainCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takahiro Ishiguro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →